NEW YORK, March 22, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Marathon Digital Holdings, Inc. (“Marathon” or the “Company”) (NASDAQ: MARA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext….
Month: March 2023
NEW YORK, March 22, 2023POMERANTZ /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Fulcrum Therapeutics, Inc. (“Fulcrum” or the “Company”) (NASDAQ: FULC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext….
SACRAMENTO, Calif., March 22, 2023 /PRNewswire/ — SBx1 2, the newly amended proposal for a price gouging penalty and oil refiner transparency, passed its first test in the California Senate Utilities, Energy and Communications Committee by a vote of 12 to 2 today. “Senate Democrats have…
Huma’s platform is ready to use, reducing the time and cost for other companies to bring regulated SaMD products to market, democratising digital health innovation across the industry Class IIb certification expands the patient population and level of disease severity that can be managed;…
Huma’s platform is ready to use, reducing the time and cost for other companies to bring regulated SaMD products to market, democratising digital health innovation across the industry Class IIb certification expands the patient population and level of disease severity that can be managed;…
SUZHOU, China, March 22, 2023 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the…
DUBLIN, March 22, 2023 /PRNewswire/ — The “Global Automotive Semiconductor Market by Component (Processor, Analog IC, Discrete power device, Sensor), Vehicle Type (Passenger Car, LCV, HCV), Fuel Type (Gasoline, Diesel, EV/HEV), Application (Powertrain, Safety, Chassis) – Forecast to…
NEW YORK, March 22, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. (“Nutanix” or the “Company”) (NASDAQ: NTNX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
SUZHOU, China, March 22, 2023 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announces that…